The Motley Fool
20 Nov 2026, 02:26 UTC · 12h ago
Tilray Has More Cash Than Debt and 71% Growth in Europe. Is This Cannabis Stock a Buy?
Impact · against what's priced in
The article confirms Tilray's successful diversification into alcohol and its strong balance sheet, but these are existing themes that do not catalyze a price change. The lack of sustainable profitability remains the primary headwind preventing a valuation re-rating.
- TLRY+0.10
No priced-in read yet
- In context
Tilray has successfully pivoted to a diversified consumer staples model where alcohol revenues ($101.5 million) now significantly outweigh cannabis revenues ($56.1 million), though sustainable profitability remains elusive.
Read from the article alone

Search tags




